Introduction
============

Arteriovenous malformations (AVMs) of the central nervous system are generally considered as congenital disorders that result from aberrant differentiation of the mesoderm during embryonic development. AVMs are composed of abnormally developed dilated arteries and veins and are characterized microscopically by the absence of a capillary network.^[@B1]--[@B4]^ Although many studies have addressed the epidemiological characteristics, natural history, radiological features, and clinical behavior of AVMs, less is known about the molecular properties of these lesions.^[@B1]--[@B4]^ Recent studies have revealed abnormal expression of angiogenic growth factors and their receptors compared with that in normal brain tissue.^[@B5]--[@B8]^ Moreover, we have reported that AVM lesions display DNA fragmentation and increased expression of apoptosis-related factors.^[@B9]--[@B11]^ In this study, we examined differential gene expression in AVMs and analyzed this expression in relation to clinical manifestations in Japanese patients.

Materials and Methods
=====================

I.. Patients
------------

Eleven specimens from patients with cerebral AVMs were used in this study. All samples were obtained during surgery and were snap-frozen in liquid nitrogen. The relevant clinical and lesion features of the cases are summarized in [Table 1](#T1){ref-type="table"}.

II.. Preparation of RNA
-----------------------

RNA was isolated from the specimens which is nudus including brain parenchyma as follows. Briefly, RNA*later®* (Life Technologies Inc., Carlsbad, California, USA) was added at a volume of 1 ml/100 mg sample. The samples were thawed and then homogenized three times for 20 sec on ice. After the addition of 0.1 vol 1-bromo-3-chloropropane, the homogenate was vortexed for 15 sec and incubated on ice for 1 hr. After centrifugation, the upper aqueous phase was transferred to a new tube and a half volume of isopropanol was added. The solution was then mixed and incubated on ice for 1 hr. After centrifugation, the supernatant was removed. The RNA pellet was washed with 80% ethanol and resuspended in diethylpyrocarbonate-treated water. The RNA was affinity column-purified using an RNeasy Mini Kit (Qiagen Inc., Valencia, California, USA) according to the manufacturer\'s protocol. Control RNA was extracted from a middle cerebral artery and a cortical tissue sample from a Caucasian male.

III.. Microarray analysis
-------------------------

Microarray analysis was conducted by Hokkaido System Science Co. Ltd. (Sapporo). Total RNA was extracted from three biological replicates of each sample, and then it was used for cRNA synthesis. The resulting cRNA was subsequently labeled with Cyanin3 using a Quick Amp Labeling Kit (Agilent Technologies Inc., Santa Clara, California, USA), and purified using RNeasy mini spin columns (Qiagen) to generate the cRNA target solution. The cRNA target solution was then hybridized to the microarray (Arabidopsis Oligo DNA microarray ver. 4.0; Agilent Technologies). After washing and air-drying, the slide was scanned at a resolution of 5 *μ*m using a microarray scanner (Agilent Technologies). The digitalized data were imported into software (GeneSpring GX 10; Agilent Technologies) and normalized to shift to the 75th percentile. The following flagged features were cut off: features that were not positive and significant, and features that were not above background levels. After filtering for flags, 32 348 probes remained. On the microarray, some genes are represented by several oligonucleotides that have distinct 60-mer sequences from different regions within the same gene.

Results
=======

[Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"} indicate the genes that displayed an absolute fold change of at least ± 300. We categorized these genes into four groups: death-related, neuron-related, inflammation-related, and others. The differentially expressed death-related genes were *MMP9*, *LIF*, *SOD2*, *BCL2A1*, *MMP12*, and *HSPA6*. The neuron-related genes were *NPY*, *S100A9*, *NeuroD2*, *S100Abeta*, *CAMK2A*, *SYNPR*, *CHRM2*, and *CAMKV*. The inflammation-related genes were *PTX3*, *IL8*, *IL6*, *CXCL10*, *GBP1*, *CHRM3*, *CXCL1*, *IL1R2*, *CCL18*, and *CCL13*. In addition, we classified significantly changed genes based on biological process and molecular function ([Fig. 1](#F1){ref-type="fig"}).

Next, we analyzed gene expression in relation to clinical characteristics. First, we analyzed gene expression in the samples that were or were not from deep-draining veins. We identified 32 genes that showed greater than 10-fold change in deep-draining samples ([Table 4](#T4){ref-type="table"}). Among them, *FGF9*, which is an angiogenesis-related gene, was upregulated. We next compared gene expression in those with or without preoperative embolization, and found 21 genes that showed a greater than 10-fold change in those with embolization ([Table 5](#T5){ref-type="table"}). Among them, *PTX3*, *MMP3*, and *GDNF* were downregulated in the samples with preoperative embolization. When we compared expression in the samples with or without a high-flow nidus, we identified 40 genes with a greater than 10-fold change in samples with high flow ([Table 6](#T6){ref-type="table"}). Neuron-related genes, including *NPY* and *NeuroD*, were downregulated in high-flow AVMs.

Discussion
==========

AVMs seem to have unique and relatively homogeneous molecular abnormalities that can be detected at the mRNA and protein levels. Most studies have focused on the abnormal expression of vascular endothelial growth factor and its receptors^[@B3],[@B8],[@B12]--[@B15]^ or angiogenesis or cell death-related factors and receptors. Moreover, we reported that the death receptor pathway and the NF-kappaB pathway were upregulated in AVMs.^[@B9],[@B11]^ These results indicate that dynamic vascular remodeling and neuronal death occur in and around the nidus of AVMs.^[@B16]--[@B20]^ The majority of these studies, however, have focused on only one or a few genes or protein products. Here, using microarray analysis, we were able to dissect numerous molecular pathways that interact with or counteract each other within the same samples. Our findings were, in general, consistent with previously published findings, especially for genes showing a statistically significant difference between AVMs and controls.^[@B3],[@B8],[@B12],[@B15],[@B21]^

One previous study reported an increase in IL6 protein levels in AVM tissue. In addition, the GG genotype of the *IL6* 174G \> C promoter polymorphism was associated with the clinical presentation of intracranial hemorrhage in AVMs.^[@B8],[@B13]^ As for *MMP9*, Hashimoto et al.^[@B22]^ reported that AVM samples had higher levels of total MMP9, active MMP9, pro-MMP9, TIMP1, and TIMP3 than controls. In contrast, TIMP4 levels were higher in the control brain than in the AVM specimens. In addition, MMP9 was reported to be localized to the endothelial cell/peri-endothelial cell layer and infiltrating neutrophils of AVMs. Regarding IL1, we found that *IL1R2* was elevated in our AVM samples. Fontanella et al.^[@B16]^ suggested that functional polymorphisms within the *IL1* complex gene are associated with AVMs and influence the clinical characteristics of the disease, supporting a role for proinflammatory cytokines in disease etiopathogenesis.^[@B23]^ *IL1*β promoter polymorphisms were reported to be associated with AVM susceptibility and an increased risk of intracranial hemorrhage in the AVM clinical course.^[@B16],[@B23]^ These results suggest that the inflammatory pathways, including the IL1β cytokine, play an important role in intracranial hemorrhage. In previous studies, elevated IL6 was strongly associated with IL8 and MMP12, which were both elevated at the gene level in this study.^[@B8],[@B13]^ We and others have reported brain infiltration of various types of inflammatory cells in and around the nidus of AVMs.^[@B10],[@B24]^ We identified several chemokine genes to be elevated in AVMs; chemokines may be released by these infiltrating cells.^[@B10],[@B24]^ Previously we also showed reduced neuronal density around the nidus,^[@B11]^ which may be related to our observed alterations in neuron-related genes. Our gene microarray data may help us to establish further hypotheses for testing. For example, microarray data showed inflammation-related genes including IL-8 and IL-6. These observations may lead us to anti-inflammatory treatment against AVMs. To establish this hypothesis, further study is necessary to confirm that inflammation increase the risk of AVM rupture. In addition, MMP family including *MMP9*, *MMP12*, and *MMP3* changed. This observation may lead us to perform other further analysis using MMP inhibitors.

In this study, we analyze gene expression focusing on the neuron-, death-, angiogenesis-, and inflammation-related genes. Because we and others indicated the role of these pathways in cerebral AVMs.^[@B5],[@B9]--[@B14],[@B16],[@B21],[@B23],[@B24]^ Decreased expression of neuron-related genes indicate the loss of neurons in and around the nidus. Increased expressions of death-related genes indicate cellular death of neurons, infiltrating and vascular cells. In addition, increased expression of angiogenesis and inflammation-related genes may show upregulation of these events.

We also analyzed associations between gene expression and the clinical presentation or treatment of AVMs (the presence or absence of hemorrhage, deep-draining veins, embolization, and high-flow), focusing on the neuron-, death-, angiogenesis-, and inflammation-related genes. A deep-draining system may cause venous congestion, which can lead to neuronal loss. However, our data did not indicate neuronal loss because *FGF9*, which can induce angiogenesis, was upregulated. We focused on inflammation-related genes in relation to preoperative embolization, and demonstrated downregulation of several genes in embolized samples. This may indicate that these changes are not related to preoperative embolization but instead to the operative process itself (two of these samples had intraoperative hemorrhage). In the high-flow samples, neuron-related genes, including neuropeptide Y (*NPY*), synaptotagmin 1 (*SYT1*), neurogenic differentiation 2 (*NeuroD*), and ephrin B3 (*EFNB3*) were downregulated. This may indicate that neurons and neuronal networks were injured in high-flow AVMs, and may correlate with our previous finding of neuronal loss in the perinidal area.^[@B11]^

One of the limitations of this study, and of most previous studies, is the small sample size, which can lead to false-negative or false-positive results. Clinical samples may show significant variation in the levels of a specific gene or its product, which may reflect different stages and severity of the disease or simply interindividual variation. One more limitation of the study, during surgical process gene expression may be affected with local ischemia, inflammation, mechanical compression and coagulation. Microarray analysis on a large number of clinical specimens with a well-characterized clinical background is necessary to validate our findings. In addition, it should be noted that the correlation between gene expression and that of its protein product is extremely variable. Transcription efficiency, post-transcriptional modification, and protein metabolism can all independently affect gene and protein levels.

In conclusion, we examined gene expression in AVMs by microarray analysis. Using our data, we are able to generate and test new hypotheses to explore AVM pathophysiology. Microarray analysis is a useful technique to study clinical specimens from patients with brain vascular malformations.

![Classified genes with significantly altered expression based on biological process (A) and molecular function (B).](nmc-54-163-g1){#F1}

###### 

Clinical summary of the patients

  Case   Age   Sex   Hemorrhage   High flow   Deep   Embolization   Seizure   Size   S-M grade   Location
  ------ ----- ----- ------------ ----------- ------ -------------- --------- ------ ----------- ------------------
  1      60    M     No           Yes         No     No             No        3 cm   2           Occipital
  2      2     F     Yes          Yes         Yes    No             No        5 cm   4           Frontal
  3      28    F     No           No          No     No             Yes       2 cm   1           Temporal
  4      32    M     No           Yes         No     Yes            Yes       2 cm   1           Frontal
  5      49    M     Yes          Yes         Yes    No             No        3 cm   2           Frontal
  6      25    M     Yes          Yes         No     No             No        2 cm   2           Occipital
  7      28    M     No           Yes         No     No             Yes       4 cm   2           Frontal
  8      17    F     No           No          Yes    Yes            No        5 cm   4           Cerebellum
  9      29    F     Yes (op)     Yes         No     Yes            No        4 cm   2           Temporooccipital
  10     45    M     Yes          Yes         No     No             No        3 cm   2           Parietal
  11     38    M     No           Yes         No     No             No        2 cm   1           Parietal

F: female, M: male, op: intraoperative hemorrhage, S-M: Spetzler and Martin.

###### 

Genes with altered expression in cerebral arteriovenous malformation Part 1

  ProbeName      Regulation   Common name       Category   Description
  -------------- ------------ ----------------- ---------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  A_23_P166848   Up           LTF               O          Homo sapiens lactotransferrin (LTF), mRNA
  A_23_P40174    Up           MMP9              D          Homo sapiens matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (MMP9), mRNA
  A_23_P207520   Up           COL1A1            O          Homo sapiens mRNA for prepro-alpha1(I) collagen
  A_23_P212914   Up           RUFY3             O          Homo sapiens RUN and FYVE domain containing 3 (RUFY3), transcript variant 1, mRNA
  A_23_P121064   Up           PTX3              I          Homo sapiens pentraxin-related gene, rapidly induced by IL-1 beta (PTX3), mRNA
  A_24_P122137   Up           LIF               D          Homo sapiens leukemia inhibitory factor (cholinergic differentiation factor) (LIF), mRNA
  A_23_P53137    Up           HBG1              O          Homo sapiens hemoglobin, gamma A (HBG1), mRNA
  A_32_P87013    Up           IL8               I          Homo sapiens interleukin 8 (IL8), mRNA
  A_32_P70158    Up           LILRB3            O          Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 (LILRB3), transcript variant 2, mRNA
  A_23_P142533   Up           COL3A1            O          Homo sapiens collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) (COL3A1), mRNA
  A_24_P24371    Up           ENST00000390543   O          Immunoglobulin heavy chain C gene segment \[Source: IMGT/GENE_DB; Acc: IGHG4\]
  A_23_P71037    Up           IL6               A, I       Homo sapiens interleukin 6 (interferon, beta 2) (IL6), mRNA
  A_23_P81898    Up           UBD               O          Homo sapiens ubiquitin D (UBD), mRNA
  A_23_P324384   Up           RPS4Y2            O          Homo sapiens ribosomal protein S4, Y-linked 2 (RPS4Y2), mRNA
  A_32_P385587   Up           ALAS2             O          Homo sapiens aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia) (ALAS2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA
  A_24_P935819   Up           SOD2              D          Homo sapiens superoxide dismutase 2, mitochondrial, mRNA (cDNA clone MGC: 21350 IMAGE: 4184203), complete cds
  A_24_P303091   Up           CXCL10            I          Homo sapiens chemokine (C-X-C motif) ligand 10 (CXCL10), mRNA
  A_23_P106602   Up           CRISPLD2          O          Homo sapiens cysteine-rich secretory protein LCCL domain containing 2 (CRISPLD2), mRNA
  A_23_P170233   Up           CSTA              O          Homo sapiens cystatin A (stefin A) (CSTA), mRNA
  A_23_P158817   Up           IGH@              O          Homo sapiens cDNA FLJ27104 fis, clone SPL04981, highly similar to Ig gamma-2 chain C region
  A_24_P169873   Up           ENST00000390539   O          Immunoglobulin heavy chain C gene segment \[Source: IMGT/GENE_DB; Acc: IGHA2\]
  A_23_P62890    Up           GBP1              I          Homo sapiens guanylate binding protein 1, interferon-inducible, 67kDa (GBP1), mRNA
  A_32_P22654    Up           ALAS2             O          Homo sapiens aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia) (ALAS2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA
  A_23_P33723    Up           CD163             O          Homo sapiens CD163 molecule (CD163), transcript variant 1, mRNA
  A_32_P39440    Up           BC030813          O          Homo sapiens cDNA clone MGC: 22645 IMAGE: 4700961, complete cds
  A_23_P23048    Up           S100A9            N          Homo sapiens S100 calcium binding protein A9 (S100A9), mRNA
  A_23_P256470   Down         NPY               N          Homo sapiens neuropeptide Y (NPY), mRNA
  A_23_P205428   Down         FOXG1             O          Homo sapiens forkhead box G1B (FOXG1B), mRNA \[NM_005249\]
  A_24_P817236   Down         ENST00000366569   O          Muscarinic acetylcholine receptor M3 \[Source: Uniprot/SWISSPROT; Acc: P20309\]
  A_24_P142343   Down         HRNBP3            O          Homo sapiens hypothetical protein LOC146713 (HRNBP3), mRNA
  A_24_P500584   Down         XIST              O          Homo sapiens X (inactive)-specific transcript (XIST) on chromosome X
  A_32_P85360    Down         THC2770932        O          Unknown
  A_24_P347319   Down         KCNC2             O          Homo sapiens potassium voltage-gated channel, Shaw-related subfamily, member 2 (KCNC2), transcript variant 1, mRNA
  A_23_P401472   Down         CHRM3             I          Homo sapiens cholinergic receptor, muscarinic 3 (CHRM3), mRNA
  A_32_P142818   Down         DLX1              O          Homo sapiens distal-less homeobox 1 (DLX1), transcript variant 1, mRNA
  A_23_P67569    Down         PRG2              O          Homo sapiens plasticity-related gene 2 (PRG2), mRNA

A: angiogenesis, D: death, I: inflammation, N: neuron, O: others.

###### 

Genes with altered expression in cerebral arteriovenous malformation Part 2

  ProbeName      Regulation   Common name   Category   Description
  -------------- ------------ ------------- ---------- --------------------------------------------------------------------------------------------------------------------------------------------------------------
  A_24_P335092   Up           SAA1          O          Homo sapiens serum amyloid A1 (SAA1), transcript variant 1, mRNA
  A_23_P43979    Up           M87790        O          Human (hybridoma H210) anti-hepatitis A immunoglobulin lambda chain variable region, constant region, complementarity-determining regions mRNA, complete cds
  A_23_P434809   Up           S100A8        N          Homo sapiens S100 calcium binding protein A8 (S100A8), mRNA
  A_23_P7144     Up           CXCL1         I          Homo sapiens chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) (CXCL1), mRNA
  A_23_P64539    Up           HBG1          O          Homo sapiens hemoglobin, gamma A (HBG1), mRNA
  A_23_P79398    Up           IL1R2         I          Homo sapiens interleukin 1 receptor, type II (IL1R2), transcript variant 1, mRNA
  A_23_P99515    Up           C13orf33      O          Homo sapiens chromosome 13 open reading frame 33 (C13orf33), mRNA
  A_24_P357847   Up           BC030813      O          Homo sapiens cDNA clone MGC: 22645 IMAGE: 4700961, complete cds
  A_23_P431388   Up           SPOCD1        O          Homo sapiens SPOC domain containing 1 (SPOCD1), mRNA
  A_23_P152002   Up           BCL2A1        D          Homo sapiens BCL2-related protein A1 (BCL2A1), mRNA
  A_23_P160286   Up           PRG4          O          Homo sapiens proteoglycan 4 (PRG4), mRNA
  A_23_P90710    Up           DES           O          Homo sapiens desmin (DES), mRNA
  A_23_P259071   Up           AREG          O          Homo sapiens amphiregulin (schwannoma-derived growth factor) (AREG), mRNA
  A_32_P116488   Up           THC2677011    O          Unknown
  A_24_P605563   Up           AY172962      O          Homo sapiens anti-rabies SOJB immunoglobulin lambda light chain mRNA, complete cds
  A_23_P55270    Up           CCL18         I          Homo sapiens chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) (CCL18), mRNA
  A_23_P4773     Up           LILRB5        O          Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 (LILRB5), transcript variant 2, mRNA
  A_23_P259314   Up           RPS4Y1        O          Homo sapiens ribosomal protein S4, Y-linked 1 (RPS4Y1), mRNA
  A_23_P26965    Up           CCL13         I          Homo sapiens chemokine (C-C motif) ligand 13 (CCL13), mRNA
  A_32_P192842   Up           BM129308      O          if20d02.x1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA clone IMAGE: 5677082 3′, mRNA sequence
  A_23_P340698   Up           MMP12         D          Homo sapiens matrix metallopeptidase 12 (macrophage elastase) (MMP12), mRNA
  A_23_P114903   Up           HSPA6         D          Homo sapiens heat shock 70kDa protein 6 (HSP70B′) (HSPA6), mRNA
  A_32_P200144   Up           IGH@          O          Homo sapiens cDNA FLJ27104 fis, clone SPL04981, highly similar to Ig gamma-2 chain C region
  A_32_P45738    Down         PGAM1         O          Homo sapiens phosphoglycerate mutase 1 (brain) (PGAM1), mRNA
  A_23_P60130    Down         MAL2          O          Homo sapiens mal, T-cell differentiation protein 2 (MAL2), mRNA
  A_23_P355377   Down         SLC12A5       O          Homo sapiens solute carrier family 12, (potassium-chloride transporter) member 5 (SLC12A5), mRNA
  A_32_P25295    Down         NEUROD2       N          Homo sapiens neurogenic differentiation 2 (NEUROD2), mRNA
  A_23_P2543     Down         CUX2          O          Homo sapiens cut-like 2 (Drosophila) (CUTL2), mRNA
  A_24_P380311   Down         CAMK2A        N          Homo sapiens calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha (CAMK2A), transcript variant 1, mRNA
  A_23_P302568   Down         SLC30A3       O          Homo sapiens solute carrier family 30 (zinc transporter), member 3 (SLC30A3), mRNA
  A_23_P80718    Down         SYNPR         N          Homo sapiens synaptoporin (SYNPR), mRNA
  A_23_P145606   Down         CHRM2         N          Homo sapiens cholinergic receptor, muscarinic 2 (CHRM2), transcript variant 1, mRNA
  A_23_P29680    Down         CAMKV         N          Homo sapiens CaM kinase-like vesicle-associated (CAMKV), mRNA
  A_23_P77731    Down         CRYM          O          Homo sapiens crystallin, mu (CRYM), transcript variant 1, mRNA
  A_23_P252817   Down         SST           O          Homo sapiens somatostatin (SST), mRNA
  A_23_P35725    Down         ANO3          O          Homo sapiens transmembrane protein 16C (TMEM16C), mRNA
  A_23_P157926   Down         LINGO2        O          Homo sapiens leucine rich repeat and Ig domain containing 2 (LINGO2), mRNA
  A_23_P408195   Down         TMEM155       O          Homo sapiens transmembrane protein 155 (TMEM155), mRNA

A: angiogenesis, D: death, I: inflammation, N: neuron, O: others.

###### 

Clinical presentation and gene expression (deep-draining veins)

  ProbeName      Fold change   Regulation   Common name   Category   Description
  -------------- ------------- ------------ ------------- ---------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  A_23_P24294    17.487488     Up           SLC17A6       O          Homo sapiens solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 (SLC17A6), mRNA
  A_32_P164593   12.236315     Up           ZMAT4         O          Homo sapiens zinc finger, matrin type 4 (ZMAT4), mRNA
  A_23_P334308   10.814596     Up           MTUS2         O          Homo sapiens KIAA0774 (KIAA0774), transcript variant 1, mRNA
  A_23_P2283     14.029393     Up           TAC3          O          Homo sapiens tachykinin 3 (neuromedin K, neurokinin beta) (TAC3), transcript variant 1, mRNA
  A_23_P92860    12.137709     Up           CCNO          O          Homo sapiens cyclin U (CCNU), mRNA
  A_24_P142343   21.59073      Up                         O          Homo sapiens hypothetical protein LOC146713 (HRNBP3), mRNA
  A_24_P25137    10.262987     Up           CHRM3         O          Homo sapiens cholinergic receptor, muscarinic 3 (CHRM3), mRNA
  A_32_P166733   13.562277     Up           BU686948      O          UI-CF-DU1-ado-e-06-0-UI.s1 UI-CF-DU1 Homo sapiens cDNA clone UI-CF-DU1-ado-e-06-0-UI 3′, mRNA sequence
  A_23_P8981     12.29509      Up           STAR          O          Homo sapiens steroidogenic acute regulator (STAR), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA
  A_23_P321846   15.988988     Up           KCNS1         O          Homo sapiens potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 (KCNS1), mRNA
  A_24_P54900    12.008987     Up           LNX1          O          Homo sapiens ligand of numb-protein X 1 (LNX1), mRNA
  A_24_P219474   14.443749     Up           MGAT5B        O          Homo sapiens mannosyl (alpha-1,6-)- glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B (MGAT5B), transcript variant 1, mRNA
  A_23_P144847   10.753042     Up           CDH12         O          Homo sapiens cadherin 12, type 2 (N-cadherin 2) (CDH12), mRNA
  A_23_P318616   11.135667     Up           LRTM2         O          Homo sapiens leucine-rich repeats and transmembrane domains 2 (LRTM2), mRNA
  A_32_P142818   10.828055     Up           DLX1          O          Homo sapiens distal-less homeobox 1 (DLX1), transcript variant 1, mRNA
  A_23_P140858   11.060884     Up                         O          Homo sapiens ataxin 2-binding protein 1 (A2BP1), transcript variant 4, mRNA
  A_23_P2543     15.522975     Up           CUX2          O          Homo sapiens cut-like 2 (Drosophila) (CUTL2), mRNA
  A_23_P337642   12.069429     Up           ATP2B3        O          Homo sapiens ATPase, Ca++ transporting, plasma membrane 3 (ATP2B3), transcript variant 1, mRNA
  A_24_P380311   26.18467      Up           CAMK2A        N          Homo sapiens calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha (CAMK2A), transcript variant 1, mRNA
  A_23_P13822    10.42801      Up           STYK1         O          Homo sapiens serine/threonine/tyrosine kinase 1 (STYK1), mRNA
  A_23_P65918    11.070756     Up           ITPKA         O          Homo sapiens inositol 1,4,5-trisphosphate 3-kinase A (ITPKA), mRNA
  A_23_P157027   11.949467     Up                         O          Homo sapiens hypothetical protein LOC 285878, mRNA (cDNA clone IMAGE: 5299807)
  A_23_P22723    12.559601     Up           ATP2B3        O          Homo sapiens ATPase, Ca++ transporting, plasma membrane 3 (ATP2B3), transcript variant 1, mRNA
  A_23_P132175   11.3289       Up           RTN4R         O          Homo sapiens reticulon 4 receptor (RTN4R), mRNA
  A_23_P79968    10.7763815    Up           PCSK2         O          Homo sapiens proprotein convertase subtilisin/kexin type 2 (PCSK2), mRNA
  A_23_P105803   11.011639     Up           FGF9          A          Homo sapiens fibroblast growth factor 9 (glia-activating factor) (FGF9), mRNA
  A_23_P53137    11.880983     Down         HBG1          O          Homo sapiens hemoglobin, gamma A (HBG1), mRNA
  A_32_P385587   15.667379     Down         ALAS2         O          Homo sapiens aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia) (ALAS2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA
  A_23_P121596   19.073265     Down         PPBP          I          Homo sapiens pro-platelet basic protein (chemokine \[C-X-C motif\] ligand 7) (PPBP), mRNA
  A_32_P168342   10.181584     Down         C6orf25       O          G6b protein precursor \[Source: Uniprot/SWISSPROT; Acc: O95866\]
  A_23_P87346    14.329434     Down         HBD           O          Homo sapiens hemoglobin, delta (HBD), mRNA
  A_24_P79403    13.201708     Down         PF4           O          Homo sapiens platelet factor 4 (chemokine \[C-X-C motif\] ligand 4) (PF4), mRNA

A: angiogenesis, D: death, I: inflammation, N: neuron, O: others.

###### 

Clinical presentation and gene expression (embolization)

  ProbeName      Fold change   Regulation   Common name   Category   Description
  -------------- ------------- ------------ ------------- ---------- ---------------------------------------------------------------------------------------------------------------
  A_23_P62857    12.33438      Down         A_23_P62857   O          PLA2G2A
  A_23_P73526    13.889064     Down         CITED1        O          Homo sapiens Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 (CITED1), mRNA
  A_23_P121064   32.46276      Down         PTX3          I          Homo sapiens pentraxin-related gene, rapidly induced by IL-1 beta (PTX3), mRNA
  A_32_P107372   15.64205      Down         GBP1          I          Homo sapiens guanylate binding protein 1, interferon-inducible, 67kDa (GBP1), mRNA
  A_23_P78037    15.200374     Down         CCL7          I          Homo sapiens chemokine (C-C motif) ligand 7 (CCL7), mRNA
  A_23_P161698   16.020575     Down         MMP3          D          Homo sapiens matrix metallopeptidase 3 (stromelysin 1, progelatinase) (MMP3), mRNA
  A_32_P377880   13.725988     Down         GDNF          N          Glial cell line-derived neurotrophic factor precursor (Astrocyte- derived trophic factor 1) (ATF-1)
  A_32_P5417     17.92484      Down         CA946373      O          CA946373 ni04a06.x1 Human lacrimal gland: ni Homo sapiens cDNA clone ni04a06 5′, mRNA sequence
  A_23_P62890    16.525377     Down         GBP1          O          Homo sapiens guanylate binding protein 1, interferon-inducible, 67kDa (GBP1), mRNA
  A_23_P52067    12.040656     Down         GRHL3         O          Homo sapiens grainyhead-like 3 (Drosophila) (GRHL3), transcript variant 2, mRNA
  A_24_P932887   45.99536      Down         SPOCD1        O          Homo sapiens cDNA FLJ39908 fis, clone SPLEN2017620
  A_23_P63254    12.1611395    Down         SFN           O          Homo sapiens stratifin (SFN), mRNA
  A_24_P335092   50.85907      Down         SAA1          O          Homo sapiens serum amyloid A1 (SAA1), transcript variant 1, mRNA
  A_23_P336554   11.759418     Down         IL1RAP        I          Homo sapiens interleukin 1 receptor accessory protein (IL1RAP), transcript variant 2, mRNA
  A_23_P431388   24.716013     Down         SPOCD1        O          Homo sapiens SPOC domain containing 1 (SPOCD1), mRNA
  A_32_P15544    7.8432913     Down         PRIMA1        O          Homo sapiens proline rich membrane anchor 1 (PRIMA1), mRNA
  A_24_P923854   15.754891     Down         AF113674      O          Homo sapiens clone FLB1727 PRO0398 mRNA, complete cds
  A_23_P104073   11.630592     Down         S100A3        N          Homo sapiens S100 calcium binding protein A3 (S100A3), mRNA
  A_32_P116488   11.215696     Down         THC2677011    O          Unknown
  A_24_P379521   28.073503     Down         BM702245      O          UI-E-CQ1-aey-h-03-0-UI.r1 UI-E-CQ1 Homo sapiens cDNA clone UI-E-CQ1-aey-h-03-0-UI 5′, mRNA sequence
  A_23_P306203   20.476131     Down         SAA2          O          Homo sapiens serum amyloid A2 (SAA2), mRNA

A: angiogenesis, D: death, I: inflammation, N: neuron, O: others.

###### 

Clinical presentation and gene expression (high-flow)

  ProbeName      Fold change   Regulation   Common name       Category   Description
  -------------- ------------- ------------ ----------------- ---------- ----------------------------------------------------------------------------------------------------------------------
  A_24_P933319   13.79898      Down         RAB3B             O          Ras-related protein Rab-3B \[Source: Uniprot/SWISSPROT; Acc: P20337\]
  A_23_P415541   26.580494     Down         GPR26             O          Homo sapiens G protein-coupled receptor 26 (GPR26), mRNA
  A_32_P51005    12.428625     Down         AL834342          O          Homo sapiens mRNA; cDNA DKFZp761P2314 (from clone DKFZp761P2314)
  A_32_P66804    12.633398     Down         PTPRN2            O          Homo sapiens protein tyrosine phosphatase, receptor type, N polypeptide 2 (PTPRN2), transcript variant 1, mRNA
  A_23_P256470   56.132885     Down         NPY               N          Homo sapiens neuropeptide Y (NPY), mRNA
  A_32_P183367   17.20502      Down         BRUNOL4           O          PREDICTED: Homo sapiens bruno-like 4, RNA binding protein (Drosophila) (BRUNOL4), mRNA
  A_32_P152195   11.834058     Down         STAC2             O          Homo sapiens SH3 and cysteine rich domain 2 (STAC2), mRNA
  A_24_P307964   21.591301     Down         SOHLH1            O          Homo sapiens spermatogenesis and oogenesis specific basic helix-loop-helix 1 (SOHLH1), mRNA
  A_32_P323      13.151337     Down         BC037323          O          Homo sapiens cDNA clone IMAGE: 5261489
  A_32_P3476     16.78356      Down         RPRML             O          Homo sapiens reprimo-like (RPRML), mRNA
  A_24_P393571   15.406029     Down         GDA               O          Homo sapiens guanine deaminase (GDA), mRNA
  A_23_P392654   13.023042     Down         SPHKAP            O          Homo sapiens SPHK1 (sphingosine kinase type 1) interacting protein (SKIP), mRNA
  A_24_P479551   14.176087     Down         UBE2QL1           O          Homo sapiens mRNA, clone: TH049G03
  A_24_P944714   11.678925     Down         ENST00000381655   O          Probable phospholipid-transporting ATPase IB (EC 3.6.3.1) (ATPase class I type 8A member 2) (ML-1)
  A_32_P197156   27.140347     Down         BI758260          O          603029911F1 NIH_MGC_114 Homo sapiens cDNA clone IMAGE:5200131 5′, mRNA sequence \[BI758260\]
  A_23_P162010   15.891171     Down         CCKBR             O          Homo sapiens cholecystokinin B receptor (CCKBR), mRNA
  A_23_P10025    11.819316     Down         NELL2             O          Homo sapiens NEL-like 2 (chicken) (NELL2), mRNA
  A_23_P36795    14.929889     Down         SYT1              N          Homo sapiens synaptotagmin I (SYT1), mRNA
  A_23_P67569    21.238386     Down                           O          Homo sapiens plasticity-related gene 2 (PRG2), mRNA
  A_32_P25295    28.055656     Down         NEUROD2           N          Homo sapiens neurogenic differentiation 2 (NEUROD2), mRNA
  A_24_P940006   11.538975     Down         EFNB3             A          Homo sapiens ephrin-B3 (EFNB3), mRNA
  A_32_P84369    12.537511     Down         FAM153B           O          Homo sapiens hypothetical protein LOC202134 (LOC202134), mRNA
  A_23_P429601   25.979113     Down         GALNTL5           O          Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5 (GALNTL5), mRNA
  A_23_P215283   11.123473     Down         TAC1              O          Homo sapiens tachykinin, precursor 1 (TAC1), transcript variant beta, mRNA
  A_23_P50928    14.404265     Down         C1QL2             O          Homo sapiens complement component 1, q subcomponent-like 2 (C1QL2), mRNA
  A_23_P60775    10.825105     Down         BRUNOL5           O          Homo sapiens bruno-like 5, RNA binding protein (Drosophila) (BRUNOL5), mRNA
  A_23_P357207   13.065118     Down         MRAP2             O          Homo sapiens chromosome 6 open reading frame 117 (C6orf117), mRNA
  A_23_P204885   11.051615     Down         PCDH20            O          Homo sapiens protocadherin 20 (PCDH20), mRNA
  A_24_P548966   15.763181     Down         RAB3B             O          Ras-related protein Rab-3B \[Source:Uniprot/SWISSPROT;Acc:P20337\]
  A_23_P92730    19.459343     Down         HSPB3             D          Homo sapiens heat shock 27kDa protein 3 (HSPB3), mRNA
  A_23_P252817   20.574722     Down         SST               O          Homo sapiens somatostatin (SST), mRNA
  A_23_P428485   10.119454     Down         SPHKAP            O          Homo sapiens SPHK1 (sphingosine kinase type 1) interacting protein (SKIP), mRNA
  A_32_P45844    13.05868      Down         BX110856          O          BX110856 Soares adult brain N2b4HB55Y Homo sapiens cDNA clone IMAG-p998M09331, mRNA sequence
  A_23_P368794   22.000626     Down         TCERG1L           O          Homo sapiens transcription elongation regulator 1-like (TCERG1L), mRNA
  A_24_P266131   15.002172     Down         FSTL4             O          Homo sapiens follistatin-like 4 (FSTL4), mRNA
  A_23_P100022   16.488022     Down         SV2B              O          Homo sapiens synaptic vesicle glycoprotein 2B (SV2B), mRNA
  A_23_P324706   11.529245     Down         FAM153A           O          Homo sapiens mRNA for KIAA0752 protein, partial cds
  A_23_P51019    13.003195     Down         SCN2A             O          Homo sapiens sodium channel, voltage-gated, type II, alpha subunit (SCN2A), transcript variant 1, mRNA
  A_23_P408195   28.795895     Down         TMEM155           O          Homo sapiens transmembrane protein 155 (TMEM155), mRNA
  A_24_P38290    10.143327     Down         TAC1              O          Homo sapiens tachykinin, precursor 1 (TAC1), transcript variant beta, mRNA

A: angiogenesis, D: death, I: inflammation, N: neuron, O: others.
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